Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Tissue formulations

In common silicate glasses silicon dioxide is used. If instead of silicon dioxide, phosphorous pentoxide is used, a kind of phosphate glass is obtained. Some phosphate glasses are water soluble, as well as biocompatible and can be used in biodegradable tissue formulations. [Pg.252]

Contact lenses can be subdivided further according to whether they are tinted and/or disposable and by the material from which they are formulated. In addition, contact lenses can be used medically for the treatment of certain eye diseases and injuries by providing a protective cover while the tissue heals itself or by acting as a dmg deflvery system such lenses are termed therapeutic lenses, bandage lenses, or shields. [Pg.100]

Functional Nail-Care Products. Cuticle removers are solutions of dilute alkaHes that faciHtate removal, or at least softeniag, of the cuticle. Formulations containing as much as 5% potassium hydroxide have been reported. Such preparations may contain about 10% glycerine to reduce dryiag, and thickeners, such as clays, to reduce mnoff Lipids and other conditioners are iacluded to reduce damage to tissues other than the cuticle. [Pg.300]

Components/ mechanism of action Light-activated polyethylene-glycol (PEG) polymer sealant for lung tissue. Monomeric (2-octyl cyanoacrylate) formulation tissue adhesive for skin closure. Bovine albumin cross-linked with gluteraldehyde tissue adhesive/sealant. [Pg.1107]

The cl mg discovery process can be envisioned as four interconnected phases (see Figure 8.1). Generally, these are the acquisition of chemicals to be tested for biological activity, the determination of the activity of those chemicals on biological systems (pharmacodynamics), the formulation of the most active of these for therapeutic testing in humans (pharmaceutics), and the determination of adequate delivery of the active drug to diseased tissues (pharmacokinetics). Each of these collections of processes is interconnected with the others and failure in any one of them can halt the development process. It is worth considering each process separately, as well as the relationships between them. [Pg.147]

Oral formulations of metformin are rapidly and completely absorbed. The agent is poorly bound to plasma proteins its duration of action is determined exclusively by renal elimination. Higher concentrations of metformin than in most tissues are found in the intestinal mucosa, giving tise to common side effects (irritation, diarrhoea etc.). [Pg.425]

The nasal tissue is highly vascularized and provides efficient systemic absorption. Compared with oral or subcutaneous administration, nasal administration enhances bioavailability and improves safety and efficacy. Chitosan enhances the absorption of proteins and peptide drugs across nasal and intestinal epithelia. Gogev et al. demonstrated that the soluble formulation of glycol chitosan has potential usefulness as an intranasal adjuvant for recombinant viral vector vaccines in cattle [276]. [Pg.189]

Eleven controlled diet and environment experiments have been designed in a way that can be used to investigate the effects of protein nutrition and heat and/or water stress on diet-tissue A N. Laboratory rats were raised on purified, pelletized diets in which the isotopic composition of proteins, lipids and carbohydrates were well characterized and their proportions accurately and precisely measured (Ambrose and Norr 1993). Four experiments involved manipulation of temperature and/or water availability. Of these four experiments, one used a diet with high (70%) protein concentrations and heat/water stress (36°C) and three used normal (20%) protein concentrations. Seven experiments were conducted at normal temperature (21°C) with water ad libitum. Of these seven experiments, two used diets formulated with veiy low protein (5%), three with normal protein and two with high protein concentrations. [Pg.248]

Indirect evidence indicates that dermal absorption occurs in animals. Calves dusted with a 4% dust formulation of endosulfan had neurological symptoms (tremors, twitching, convulsions) and died within a day after exposure (Nicholson and Cooper 1977). Neurological effects have also been reported in preclipped rabbits and rats after repeated application of endosulfan to the skin (Dikshith et al. 1988 Gupta and Chandra 1975). Dikshith et al. (1988) reported levels of a-, [3-, and total endosulfan in liver, kidney, brain, testes, fatty tissue, and blood 30 days after dermal application of endosulfan. [Pg.124]

Three animal studies were located regarding distribution of endosulfan in animals following dermal exposure (Dikshith et al. 1988 Hoechst 1986 Nicholson and Cooper 1977). Endosulfan was detected in the brain (0.73 ppm), liver (3.78 ppm), and rumen contents (0.10 ppm) of calves that died after dermal exposure to a dust formulation of endosulfan (Nicholson and Cooper 1977). Following a single dermal application of aqueous suspensions of 0.1, 0.83, and 10.13 mg/kg C-endosulfan to male Sprague-Dawley rats, low concentrations of endosulfan (ng/g levels) appeared in the blood and tissues (other than skin at and around the application site) after 1 hour (Hoechst 1986). The concentrations of endosulfan in the blood and tissues increased with the time of exposure and were proportional to the dose applied. The liver and kidney appeared to sequester radiolabel relative to the concentrations of radiolabel in the blood or fat. Endosulfan levels were approximately 10 times higher in the liver and kidney than in the fat, blood, and brain throughout the study (Hoechst 1986). [Pg.128]

Hyaluronic acid is a linear polysaccharide found in the highest concentrations in soft connective tissues where it fills an important structural role in the organization of the extracellular matrix (23,24). It has been used in ophthalmic preparations to enhance ocular absorption of timolol, a beta blocker used for the treatment of glaucoma (25), and in a viscoelastic tear formulation for conjunctivitis (26). The covalent binding of adriamycin and daunomycin to sodium hy-aluronate to produce water-soluble conjugates was recently reported (27). [Pg.233]

Most acute pathogens require specific growth factors normally associated with the tissues they infect but which are often normally absent in pharmaceutical formulations. They are thus unlikely to multiply in them, although they may remain viable and infective for an appreciable time in some dry products where the conditions are suitably protective. [Pg.362]

Carotenoids are also present in animal products such as eggs, lobsters, greyflsh, and various types of hsh. In higher plants, they occur in photosynthetic tissues and choloroplasts where their color is masked by that of the more predominant green chlorophyll. The best known are P-carotene and lycopene but others are also used as food colorants a-carotene, y-carotene, bixin, norbixin, capsanthin, lycopene, and P-apo-8 -carotenal, the ethyl ester of P-apo-8-carotenic acid. These are Upid-soluble compounds, but the chemical industry manufactures water-dispersible preparations by formulating coUoid suspensions by emulsifying the carotenoids or by dispersing them in appropriate colloids. ... [Pg.52]

Lymphomas not included in Working Formulation mycosis fungoides, mantle cell lymphoma, monocytoid B-cell lymphoma, mucosa-associated lymphoid tissue (MALT), anaplastic large cell lymphoma, angiocentric lymphoma, angioimmunoblastic lymphadenopathy (AILD), Castleman s disease, adult T-cell leukemia/lymphoma. [Pg.1376]

Initial tests in the rat revealed a high degree of tissue compatibility of Dat-Tyr-Hex derived polymers. More detailed tests are now in progress. In addition, tyrosine derived polymers are currently being evaluated in the formulation of an intracranial controlled release device for the release of dopamine, in the design of an intraarterial stent (to prevent the restenosis of coronary arteries after balloon angioplasty), and in the development of orthopedic implants. The use of tyrosine derived polymers in these applications will provide additional data on the biocompatibility of these polymers. [Pg.168]


See other pages where Tissue formulations is mentioned: [Pg.35]    [Pg.262]    [Pg.35]    [Pg.262]    [Pg.450]    [Pg.463]    [Pg.267]    [Pg.109]    [Pg.2135]    [Pg.527]    [Pg.1106]    [Pg.264]    [Pg.265]    [Pg.370]    [Pg.436]    [Pg.191]    [Pg.95]    [Pg.167]    [Pg.111]    [Pg.91]    [Pg.203]    [Pg.572]    [Pg.761]    [Pg.942]    [Pg.1227]    [Pg.131]    [Pg.129]    [Pg.137]    [Pg.209]    [Pg.230]    [Pg.233]    [Pg.234]    [Pg.239]    [Pg.387]    [Pg.387]    [Pg.388]    [Pg.389]    [Pg.410]   
See also in sourсe #XX -- [ Pg.72 , Pg.200 ]




SEARCH



© 2024 chempedia.info